Abstract
Two main clinical manifestations of venous thrombo-embolism (VTE) include deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT refers to a blood clot that starts in vein, usually in the deep veins of the legs or pelvis area. This blood clot (thrombus) may dislodge from its site of generation and travel through blood stream into lungs, causing PE, a potentially fatal condition. While incidence rate of VTE vary among different age groups and population, various reports are available on its differential occurrence in men and women, with contrasting data. Although any individual can succumb to VTE due to various inherited and acquired risk factors, the majority of the published data indicates that women are more prone to first incidence of venous thrombosis during different stages of life (from puberty till menopause), while men are more prone to recurrent VTE. The prevention and treatment of VTE thus poses distinct gender-specific challenges. It is extremely important for women to know the stages of life when they are more prone to develop DVT/VTE. Subsequently, women also need to have information about the risks associated with treatments using oral contraceptives, ovarian stimulation, pregnancy, etc. Thus the aim of this review is to (1) assess the incidence and risk factors of VTE in women and (2) to summarize the current guidelines and recommendation of VTE management. Early diagnosis of signs and symptoms of DVT/VTE and use of systematic anticoagulation therapy can prevent progression of thrombus and subsequent PE.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- COCs:
-
Combined oral contraceptives
- DVT:
-
Deep vein thrombosis
- HRT:
-
Hormone replacement therapy
- OHSS:
-
Ovarian hyperstimulation syndrome
- PE:
-
Pulmonary embolism
- UFH:
-
Unfractioned heparin
- VKAs:
-
Vitamin K-antagonists
- VTE:
-
Venous thrombo-embolism
References
Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117:93–102
Alotaibi GS, Wu C, Senthilselvan A, McMurtry MS (2016) Secular trends in incidence and mortality of acute venous thromboembolism: the AB-VTE population-based study. Am J Med 129(8):879.e19–879.e25
Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 151:933–938
Barnes PM, Adams PF, Powell-Griner E (2008) Health characteristics of the Asian adult population: United States, 2004–2006. Adv Data 1–22
Barsoum MK, Heit JA, Ashrani AA, Leibson CL, Petterson TM, Bailey KR (2010) Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb Res 126:373–378
Blann AD, Lip GY (2001) Virchow’s triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. Thromb Res 101(4):321–327
Bleker SM, Coppens M, Middeldorp S (2014) Sex, thrombosis and inherited thrombophilia. Blood Rev 28(3):123–133
Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP (2000) Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med 160(1):49–52
Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS (1995) Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 102(10):767–772
Chipwete SE, Bugren S, Rafla N (2009) Thrombosis post ovarian hyperstimulation. Fertil Steril 91(5):1956.e13–1956.e14
Christiansen SC, Lijfering WM, Helmerhorst FM, Rosendaal FR, Cannegieter SC (2010) Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event. J Thromb Haemost 8(10):2159–2168
Coutinho JM, Ferro JM, Canhão P, Barinagarrementeria F, Cantú C, Bousser MG, Stam J (2009) Cerebral venous and sinus thrombosis in women. Stroke 40(7):2356–2361
Cushman M, Glynn RJ, Goldhaber SZ, Moll S, Bauer KA, Dietcher S, Shrivastava S, Ridker PM (2006) Hormonal factors and risk of recurrent venous thrombosis: the Prevention of Recurrent Venous Thromboembolism trial. J Thromb Haemost 4(10):2199–2203
De Stefano V, Finazzi G, Mannucci PM (1996) Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 87(9):3531–3544
Deguchi H, Pecheniuk NM, Elias DJ, Averell PM, Griffin JH (2005) High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation 112:893–899
Delluc A, Tromeur C, Le Ven F, Gouillou M, Paleiron N, Bressollette L, Nonent M, Salaun PY, Lacut K, Leroyer C, Le Gal G, Couturaud F, Mottier D, EPIGETBO Study Group (2016) Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France. Thromb Haemost 116(5):967–974
Devis P, Knuttinen MG (2017) Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management. Cardiovasc Diagn Ther 7(Suppl 3):S309–S319
Douketis J, Tosetto A, Marcucci M, Baglin T, Cosmi B, Cushman M, Kyrle P, Poli D, Tait RC, Iorio A (2011) Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. Br Med J 342:d813
Galanaud JP, Kahn SR (2014) Postthrombotic syndrome: a 2014 update. Curr Opin Cardiol 29(6):514–519
Gomes MP, Deitcher SR (2004) Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med 164:1965–1976
Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd (2005) Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 143(10):697–706
Heit JA, Spencer FA, White RH (2016) The epidemiology of venous thromboembolism. J Thromb Thrombolysis 41(1):3–14
Ilahi OA, Reddy J, Ahmad I (2005) Deep venous thrombosis after knee arthroscopy: a meta-analysis. Arthroscopy 21:727–730
James AH, Grotegut CA, Brancazio LR, Brown H (2007) Thromboembolism in pregnancy: recurrence and its prevention. Semin Perinatol 31(3):167–175
Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C (1995) Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 346(8990):1589–1593
Johansson M, Johansson L, Lind M (2014) Incidence of venous thromboembolism in northern Sweden (VEINS): a population-based study. Thromb J 12(1):6
Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W (2006) Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol 28:111–116
Kemmeren JM, Algra A, Grobbee DE (2001) Third generation oral contraceptives andrisk of venous thrombosis: meta-analysis. BMJ 323(7305):131–134
Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345(8943):152–155
Kumar DR, Hanlin E, Glurich I, Mazza JJ, Yale SH (2010) Virchow’s contribution to the understanding of thrombosis and cellular biology. Clin Med Res 8(3–4):168–172
Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S (2004) The risk of recurrent venous thromboembolism in men and women. NEJM 350(25):2558–2563
Laczkovics C, Grafenhofer H, Kaider A, Quehenberger P, Simanek R, Mannhalter C, Lechner K, Pabinger I (2007) Risk of recurrence after a first venous thromboembolic event in young women. Haematologica 92(9):1201–1207
Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, Crowther M (2012) Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e495S–e530S
Linnemann B, Zgouras D, Schindewolf M, Schwonberg J, Jarosch-Preusche M, Lindhoff-Last E (2008) Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry. Blood Coagul Fibrinolysis 19(2):159–165
Mahajan N, Naidu P, Gupta S, Rani K (2015) Deep venous thrombosis in a patient undergoing In-vitro fertilization with oocyte donation. J Hum Reprod Sci 8(3):182–185
Molina JA, Jiang ZG, Heng BH, Ong BK (2009) Venous thromboembolism at the National Healthcare Group, Singapore. Ann Acad Med Singap 38(6):470–478
Muñoz FJ, Mismetti P, Poggio R, Valle R, Barrón M, Guil M, Monreal M (2008) RIETE Investigators. Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest 133(1):143–148
Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5:692–699
Nordström M, Lindblad B, Bergqvist D, Kjellström T (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 232(2):155–160
Oger E (2000) Incidence of venous thromboembolism: a community-based study in Western France: EPI-GETBP Study Group: Groupe d’Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 83:657–660
Oklu R, Wicky S (2013) Catheter-directed thrombolysis of deep venous thrombosis. Semin Thromb Hemost 39(4):446–451
Ota S, Yamada N, Ogihara Y, Tsuji A, Ishikura K, Nakamura M, Wada H, Ito M (2011) High plasma level of factor VIII: an important risk factor for venous thromboembolism. Circ J 75(6):1472–1475
Ou YC, Kao YL, Lai SL, Kung FT, Huang FJ, Chang SY, ChangChien CC (2003) Thromboembolism after ovarian stimulation: successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: case report. Hum Reprod 18(11):2375–2381
Pabinger I, Grafenhofer H, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K, Kaider A (2002) Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood 100(3):1060–1062
Palareti G (2012) Recurrent venous thromboembolism: what is the risk and how to prevent it. Scientifica 2012:391734
Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ (2008a) Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 6(4):632–637
Pomp ER, Rosendaal FR, Doggen CJ (2008b) Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol 83:97–102
Roach REJ, Cannegieter SC, Lijfering WM (2014a) Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment. J Thromb Haemost 12(10):1593–1600
Roach REJ, Lijfering WM, Rosendaal FR, Cannegieter SC, le Cessie S (2014b) Sex difference in risk of second but not of first venous thrombosis paradox explained. Circulation 129:51–56
Rogers FB (2001) Venous thromboembolism in trauma patients: a review. Surgery 130:1–12
Rosendaal FR (2005) Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program 1–12
Rosendaal FR, Reitsma PH (2009) Genetics of venous thrombosis. J Thromb Haemost 7(Suppl 1):301–304
Sennström M, Rova K, Hellgren M, Hjertberg R, Nord E, Thurn L, Lindqvist PG (2017) Thromboembolism and in vitro fertilization—a systematic review. Acta Obstet Gynecol Scand 96(9):1045–1052
Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585–593
Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, Coll I, Felices R, Stone W, Fontcuberta J, Blangero J (2000) Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic analysis of idiopathic thrombophilia. Am J Hum Genet 67(6):1452–1459
Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, Gore JM, Goldberg RJ (2009) Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism: the Worcester VTE study. J Thromb Thrombolysis 28:401–409
Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD (1996) Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ 312:83–88. Level II-2
Stegeman BH, de Bastos M, Rosendaal FR, van HylckamaVlieg A, Helmerhorst FM, Stijnen T, Dekkers OM (2013) Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ 347:f5298
Stone J, Hangge P, Albadawi H, Wallace A, Shamoun F, Knuttien MG, Naidu S, Oklu R (2017) Deep vein thrombosis: pathogenesis, diagnosis, and medical management. Cardiovasc Diagn Ther 7(Suppl 3):S276–S284
Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes R, McBane RD, Moll S, Ansell J (2016) Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis 41(1):32–67
Taparia M, Cordingley FT, Leahy MF (2002) Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia. Eur J Haematol 68(5):307–309
Trinchero A, Scheres LJJ, Prochaska JH, Ambaglio C, Wild PS, Middeldorp S, Konstantinides SV, Barco S (2018) Sex-specific differences in the distal versus proximal presenting location of acute deep vein thrombosis. Thromb Res 172:74–79
Vaillant-Roussel H, Ouchchane L, Dauphin C, Philippe P, Ruivard M (2011) Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives. Contraception 84:e23–e30
van Hylckama Vlieg A, Helmerhorst FM, Rosendaal FR (2010) The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device. Arterioscler Thromb Vasc Biol 30:2297–2300
White RH, Zhou H, Romano PS (2003) Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 90:446–455
White RH, Zhou H, Murin S, Harvey D (2005) Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 93:98–305
White RH, Chan WS, Zhou H, Ginsberg JS (2008) Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism. Thromb Haemost 100(2):246–252
Zakai NA, McClure LA (2011) Racial differences in venous thromboembolism. J Thromb Haemost 9:1877–1882
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Srivastava, S., Garg, I., Ganju, L., Varshney, R., Kumar, B. (2022). Thrombotic Complications in Women: Risks and Prevention. In: Sobti, R., Ganju, A.K. (eds) Biomedical Translational Research. Springer, Singapore. https://doi.org/10.1007/978-981-16-8845-4_22
Download citation
DOI: https://doi.org/10.1007/978-981-16-8845-4_22
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-8844-7
Online ISBN: 978-981-16-8845-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)